ARTHEx Biotech Announces Publication in The American Journal of Human Genetics Highlighting the Discovery and Preliminary Preclinical Profile of ATX-01 for Myotonic Dystrophy Type 1 (DM1)
– Data establishes miR-23b as a disease-modifying target in DM1 and demonstrates enhanced muscle delivery and functional benefit of ATX-01...
Read moreDetails